BASSO, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 27.760
AS - Asia 9.326
EU - Europa 7.123
SA - Sud America 2.197
AF - Africa 1.666
OC - Oceania 180
Continente sconosciuto - Info sul continente non disponibili 95
AN - Antartide 1
Totale 48.348
Nazione #
US - Stati Uniti d'America 26.757
SG - Singapore 3.243
CN - Cina 2.164
HK - Hong Kong 1.654
BR - Brasile 1.603
IT - Italia 1.052
PL - Polonia 944
FI - Finlandia 809
DE - Germania 782
SE - Svezia 558
VN - Vietnam 419
UA - Ucraina 352
FR - Francia 340
RU - Federazione Russa 326
GB - Regno Unito 303
NL - Olanda 288
IN - India 137
KR - Corea 136
AT - Austria 125
CA - Canada 117
AR - Argentina 114
TR - Turchia 111
MX - Messico 109
ZA - Sudafrica 100
IQ - Iraq 91
IE - Irlanda 87
EC - Ecuador 84
ES - Italia 80
JP - Giappone 80
SA - Arabia Saudita 73
EG - Egitto 68
ID - Indonesia 68
CI - Costa d'Avorio 64
VE - Venezuela 64
CO - Colombia 61
BD - Bangladesh 60
GT - Guatemala 59
PA - Panama 58
PY - Paraguay 57
RO - Romania 56
AU - Australia 55
IL - Israele 55
MD - Moldavia 55
NI - Nicaragua 54
HR - Croazia 52
AZ - Azerbaigian 51
BE - Belgio 51
CZ - Repubblica Ceca 51
HU - Ungheria 51
CL - Cile 49
CM - Camerun 49
DK - Danimarca 49
SO - Somalia 49
ME - Montenegro 48
MG - Madagascar 48
BY - Bielorussia 47
LB - Libano 47
LC - Santa Lucia 47
CH - Svizzera 46
MA - Marocco 46
UZ - Uzbekistan 46
AE - Emirati Arabi Uniti 45
KG - Kirghizistan 45
PE - Perù 45
PR - Porto Rico 45
TH - Thailandia 45
BZ - Belize 44
CR - Costa Rica 44
DZ - Algeria 44
KZ - Kazakistan 44
ML - Mali 44
MW - Malawi 44
EE - Estonia 43
GF - Guiana Francese 43
GR - Grecia 43
PH - Filippine 43
PK - Pakistan 43
YE - Yemen 43
CD - Congo 42
IR - Iran 42
JM - Giamaica 42
JO - Giordania 42
TN - Tunisia 42
TT - Trinidad e Tobago 42
UG - Uganda 42
AO - Angola 41
BB - Barbados 41
BF - Burkina Faso 41
BW - Botswana 41
DJ - Gibuti 41
MN - Mongolia 41
UY - Uruguay 41
AF - Afghanistan, Repubblica islamica di 40
CV - Capo Verde 40
GM - Gambi 40
PT - Portogallo 40
ZM - Zambia 40
AL - Albania 39
AM - Armenia 39
CU - Cuba 39
Totale 46.344
Città #
Fairfield 3.385
Woodbridge 2.629
Ashburn 2.288
Houston 2.159
Ann Arbor 2.094
Singapore 1.984
Chandler 1.940
Hong Kong 1.597
Wilmington 1.276
Jacksonville 1.239
Cambridge 1.224
Seattle 1.136
Bytom 840
Boardman 703
Santa Clara 610
Princeton 573
Beijing 562
Medford 375
Des Moines 372
San Diego 343
Helsinki 312
Nanjing 288
Padova 259
Roxbury 219
Dong Ket 179
Munich 171
Los Angeles 154
São Paulo 139
New York 127
Guangzhou 107
Hefei 104
Ho Chi Minh City 96
Milan 88
Nanchang 86
Shenyang 82
Hebei 73
Nuremberg 72
Dublin 71
Changsha 69
Vienna 69
Abidjan 62
London 62
Jiaxing 60
Tianjin 58
Jinan 56
Brooklyn 54
Panama City 53
Norwalk 52
Buffalo 50
Managua 50
Shanghai 50
Turku 50
San Francisco 49
Warsaw 48
Castries 46
Dallas 46
Hanoi 46
Baku 45
Johannesburg 43
Chicago 42
Rio de Janeiro 42
Seoul 42
Bishkek 41
Antananarivo 40
Bamako 40
Kampala 40
Podgorica 40
Amman 39
Bridgetown 39
Rome 39
Tashkent 39
Ulan Bator 39
Djibouti 38
Libreville 38
Redwood City 38
Tokyo 38
Dakar 37
Guatemala City 37
Luanda 37
Lusaka 37
Nassau 36
Phnom Penh 36
Andorra la Vella 35
Chisinau 35
Ouagadougou 35
Phoenix 35
Praia 35
Cotonou 34
Lima 34
Montevideo 34
Riga 34
San José 34
Zhengzhou 34
Amsterdam 33
Baghdad 33
Belo Horizonte 33
Yerevan 33
Cairo 32
Conakry 32
Curitiba 32
Totale 32.575
Nome #
Is Vitamin D deficiency a risk factor for osteonecrosis of the jaw in patients with cancer? A matched case-control study. 242
A new indirect chemiluminescent immunoassay to measure anti-tissue transglutaminase antibodies 236
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation 218
Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma 218
Diagnostic testing for celiac disease 202
TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children. 201
Clarithromycin Resistance, Tumor Necrosis Factor Alpha Gene Polymorphism and Mucosal Inflammation Affect H. pylori Eradication Success. 200
Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 supports diagnosis and prognosis of PDAC-associated diabetes mellitus 195
Decreased expression and promoter methylation of the menin tumor suppressor in pancreatic ductal adenocarcinoma. 189
Peptidomic and proteomic analysis of stool for diagnosing IBD and deciphering disease pathogenesis 185
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 183
Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial 181
Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study 181
Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability 181
Computer-based-limited and personalised education management maximise appropriateness of vitamin D, vitamin B12 and folate retesting 180
Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblasts: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle genes 179
Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors 179
Quality indicators in laboratory medicine: state-of-the-art, quality specifications and future strategies 178
Mass spectrometry measurement of plasma hepcidin for the prediction of iron overload. 175
Alterations in bilirubin metabolism during extra- and intrahepatic cholestasis. 174
PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis 174
Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension 173
ME-PCR for the identification of mutated K-ras in serum and bile of pancreatic cancer patients: an unsatisfactory technique for clinical applications 167
The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathway. 167
Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry 165
Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children. 162
Lack of association for reported endocrine pancreatic cancer risk Loci in the PANDoRA consortium 161
Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications 158
Low Glucose Concentrations Induce a Similar Inflammatory Response in Monocytes from Type 2 Diabetic Patients and Healthy Subjects 157
Analytical validation of a Biochip prototype for integrated analysis of AFP-IgM and SCCA-IgM serum biomarkers in patients with liver cirrhosis and hepatocellular carcinoma 155
Interleukin 12 gene polymorphisms enhance gastric cancer risk in H pylori infected individuals 154
Plasma chromogranin A in patients with prostate cancer improves the diagnostic efficacy of free/total prostate-specific antigen determination. 153
Hyperglycemia-induced S100A8 and S100A9 expression target AKT, mTOR and NF-kB signalling in pancreatic cancer cells 153
Gastric type I carcinoid: a pilot study with human G17DT immunogen vaccination. 152
Altered lipid peroxidation/glutathione ratio in experimental extrahepatic cholestasis. 152
Pathogenesis of Helicobacter pylori in humans. 152
Spondyloarthritis: Matrix Metalloproteinasesas Biomarkers of Pathogenesis and Response to Tumor Necrosis Factor (TNF) Inhibitors 152
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. 151
Altered Intracellular Calcium Fluxes in Pancreatic Cancer Induced Diabetes Mellitus: Relevance of the S100A8 N-Terminal Peptide (NT-S100A8) 150
Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: Which is clinically effective and when? 150
Intron 2 [IVS2, T-C +4] HFE gene mutation associated with S65C causes alternative RNA splicing and is responsible for iron overload 150
Pancreatic cancer-derived S-100A8 N-terminal peptide: a diabetes cause? 149
Concanavalin A affinity pattern of CA 19-9: an in vitro and in vivo study. 149
A 2026 D peptide as the putative pancreatic cancer-associated diabetogenic factor 148
Serum elastase 1 and immunoreactive trypsin in chronic pancreatic disease: is there any relationship with trypsin inhibitors? 147
Molecular refinement of clinical staging in hepatocellular carcinoma patients evaluated for potentially curative therapies. 147
Does serum HPP in chronic pancreatic diseases indicate exocrine pancreatic dysfunction and damage ?. 146
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 146
Role of blood AFP mRNA and tumor grade in the preoperative prognostic evaluation of patients with hepatocellular carcinoma 145
Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results? 145
CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging 145
Chemiluminescence and ELISA-based serum assays for diagnosing and monitoring celiac disease in children: a comparative study. 144
AESKULISA and H-TTG/DGP screen for celiac disease diagnosis. 143
Acute reflux pancreatitis in rats: A comparison between two experimental models 143
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 142
VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study 142
Extra-hepatic cholestasis determines a reversible increase of glycoproteic tumour markers in benign and malignant diseases. 142
Does serum CAR-3 play a role in pancreatic cancer diagnosis? 142
SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells 142
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. sensitive two-test based strategy for celiac disease diagnosis. 142
Addison's disease: a survey on 633 patients in Padova. 141
Celiac disease in North Italian patients with autoimmune Addison's disease. 140
DNA repair pathways and mitochondrial DNA mutations in gastrointestinal carcinogenesis 139
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 138
Cytokines modulate MIA PaCa 2 and CAPAN-1 adhesion to extracellular matrix proteins. 137
Serum pepsinogen C: a useful marker of Helicobacter pylori eradication? 137
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 136
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. 136
Serum deoxyribonuclease and ribonuclease in pancreatic cancer and chronic pancreatitis. 135
Pancreatic cancer gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 135
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 135
IL-4 -588C>T polymorphism and IL-4 receptor alpha [Ex5+14A>G; Ex11+828A>G] haplotype concur in selecting H. pylori cagA subtype infections. 135
Biliary hyperpressure in rat extrahepatic cholestasis alters horseradish peroxidase biliary excretion. 135
Helicobacter pylori infection in children and adults: a single pathogen but different pathology 134
Immunotherapy for gastric premalignant lesions and cancer. 134
Increased antibody response to microbial antigens in patients with Crohn's disease and their unaffected first-degree relatives. 133
Clinical utility of TPS, TPA and CA19-9 measurement in pancreatic cancer 133
Does acetylsalicylic acid interfere with stimulated pancreatic secretion? An experimental study in the rat. 131
Suicide gene therapy with HSV-TK in pancreatic cancer has no effect in vivo in a mouse model 131
A new indirect chemiluminescent immunoassay to measure anti-tissue transglutaminase antibodies 131
AT1AA (Angiotensin II Type-1 Receptor Autoantibodies): Cause or Consequence of Human Primary Aldosteronism? 131
Genetics in TNF-TNFR pathway: A complex network causing spondyloarthritis and conditioning response to anti-TNFa therapy 131
Heat-induced transcription of diphtheria toxin A or its variants, CRM176 and CRM197: implications for pancreatic cancer gene therapy. 130
Celiac disease and type 1 diabetes 129
VITAMIN D:FOE OF THE IMMUNE RESPONSE IN PANCREATIC CANCER 129
MALDI-TOF peptidomic analysis of serum and post-prostatic massage urine specimens to identify prostate cancer biomarkers 129
CD44v10: an antimetastatic membrane glycoprotein for pancreatic cancer 129
Putative pancreatic cancer-associated diabetogenic factor: 2030 MW peptide 128
MMP9 and S100A9 expression in peripheral blood mononuclear cells (PBMC) are correlated with PDAC and with PDAC-associated diabetes mellitus. 127
A preliminary fastview of mitochondrial protein profile from healthy and type 2 diabetic subjects. 127
Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides 126
Effect of CagA status on the sensitivity of enzyme immunoassay in diagnosis Helicobacter pylori-infected children 126
GastroPanel: Evaluation of the usefulness in the diagnosis of gastro-duodenal mucosal alterations in children. 126
Serum antibodies anti-H. pylori and anti CagA: a comparison between four different assays. 126
Measurement of specific immunoglobulin E: Intermethod comparison and standardization 125
Convergence and cooperativity between EGFR, TGFB, insulin and S100A8/A9 signaling in PDAC 125
H. pylori infection: bacterial virulence factors and cytokine gene polymorphisms as determinants of infection outcome 125
Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk 124
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms 124
Helicobacter pylori virulence genes and host IL-1RN and IL-1b genes interplay in favoring the development of peptic ulcer and intestinal metaplasia 122
Totale 15.179
Categoria #
all - tutte 162.480
article - articoli 112.213
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 549
Totale 275.242


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.720 0 0 279 419 187 321 149 370 535 551 434 475
2021/20224.614 92 753 425 255 179 373 204 407 213 97 463 1.153
2022/20234.362 901 444 55 444 782 640 25 247 525 38 184 77
2023/20242.395 95 301 248 175 165 277 228 147 97 127 227 308
2024/202511.299 58 649 564 443 1.423 254 512 794 1.021 452 2.052 3.077
2025/20268.714 1.829 3.472 3.413 0 0 0 0 0 0 0 0 0
Totale 48.680